Frost & Sullivan Applauds Volpara Solutions’ Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer

Volpara Solutions is the only company with a dose measurement tool specifically for breast imaging

MOUNTAIN VIEW, Calif., Aug. 26, 2014 /PRNewswire/ — Based on its recent analysis of the breast imaging solutions market, Frost & Sullivan recognizes Volpara Solutions with the 2014 North American Frost & Sullivan Award for Technology Innovation Leadership. Volpara Solutions offers an innovative range of volumetric breast imaging solutions for the early detection of breast cancer. Over the past few years, the company has steadily introduced several new solutions and has expanded its global reach to cover the United States, Europe, Asia and Australia.

Volpara’s suite of quantitative solutions includes VolparaDose, VolparaDensity, VolparaAnalytics and VolparaResearch. The Density and Dose solutions are patient-specific, while the Analytics and Research solutions are clinic-wide monitoring tools.

VolparaDensity automatically generates an objective measurement of volumetric breast density and a FDA-cleared BI-RADS breast density category, while VolparaDose helps keep track of patient-specific dose exposure. VolparaAnalytics assists in quality assurance by monitoring critical elements of the breast imaging process and generating key metrics to help understand the performance of technologists, readers, and mammography and tomosynthesis machines. VolparaResearch is aimed at research facilities that are looking to analyze large datasets of breast measurement information captured across time.

“Frost & Sullivan lauds Volpara Solutions for continuous leadership in technology innovation, thoughtfulness in identifying the unmet need for dose tracking in breast imaging, and a clear vision for what analytics can achieve in the early detection and treatment of breast cancer. Furthermore, all of the applications are built to serve across both full-field digital mammography and digital tomosynthesis systems, and with multi-vendor compatibility and reproducible data,” said Frost & Sullivan Research Director, Advanced Medical Technologies Group, Siddharth Saha. “This is of high relevance in the industry, as tomosynthesis is quickly gaining currency, with 30 percent of the members of the Society of Breast Imaging in the U.S. already using it.”

VolparaDose, along with VolparaAnalytics, gives radiologists patient-specific quantitative data to help minimize dose in mammography and tomosynthesis while maintaining image quality. While several market participants offer breast density measurement tools, Frost & Sullivan confirms that Volpara Solutions is the only company with a dose measurement tool specifically for breast imaging. It is necessary to measure volumetric breast density to control the dose, and Volpara Solutions has emerged as a pioneer in leveraging the Mega Trend of Dose Reduction by acknowledging patient-specific dose tracking and reporting as a white-space opportunity.

Furthermore, by enabling radiologists to track density and dose scores across time, Volpara Solutions helps support the movement toward the personalization of breast screening. Women with lower density have a lower risk of breast cancer, and researchers are looking at incorporating breast density into risk models that may support personalized screening protocols, which can include the best adjuvant imaging options for that woman (including breast tomosynthesis, automated whole breast ultrasound, molecular breast imaging, and breast MRI) as well as the frequency of screening.

“We are very proud to be recognized for the innovative solutions we have brought to the breast imaging market and for our vision and commitment to address unmet needs in the detection, prevention and treatment of breast cancer,” noted Ralph Highnam, Ph.D., Volpara Solutions’ CEO and chief scientist. “By allowing researchers across the globe to compare data to detect geographical, racial and age-related trends, we hope to take breast cancer research to the next level, which could lead to the development of predictive analytical models that will revolutionize early detection of breast cancer and save lives.”

Each year, Frost & Sullivan presents this award to the company that has demonstrated uniqueness in developing and leveraging new technologies, which significantly impacts both the functionality and the customer value of the new products and applications. The award lauds the high R&D spend toward innovation, its relevance to the industry and the positive impact on brand perception.

Frost & Sullivan’s Best Practices Awards recognize companies in a variety of regional and global markets for outstanding achievement in areas such as leadership, technological innovation, customer service, and product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research.

About Volpara Solutions

Founded to enable radiologists to give women the most accurate information possible regarding their breast health, Volpara Solutions is the wholly owned sales and marketing arm of Matakina Technology Limited of New Zealand. Matakina’s founders and Board of Directors include John Hood, Ph.D., former Vice Chancellor of the University of Oxford, UK; Ralph Highnam, Ph.D., former CEO of Mirada Solutions, one of the University of Oxford’s most successful spin-outs of recent times, and co-author of the seminal book Mammographic Image Analysis; and Professor Sir Michael Brady, a serial entrepreneur who recently retired from the University of Oxford, where he was Professor of Information Technology for 25 years.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants.

Our “Growth Partnership” supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on “the next big thing”

Register:        Gain access to visionary innovation

Contact:

Frost & Sullivan            

Volpara Solutions

Mireya Espinoza             

Chris Joseph

P: 210. 247.3870            

P: 510.339.2293

F: 210.348.1003             

E: chris.joseph@volparasolutions.com

E: mireya.espinoza@frost.com

 

 

Ebola Comes to DR Congo

Ebola has come to the DRC. “Two out of eight cases tested in an outbreak of deadly fever in the northwest of the Democratic Republic of Congo were positive for the Ebola virus, the central African nation’s health minister confirmed on Sunday.”The results are positive. The Ebola virus is confirmed in DRC,” Felix Kabange Numbi said, referring to samples taken from people infected with the previously unidentified fever that has killed dozens since mid-August. The World Health Organization (WHO) announced on Thursday that 70 people had died in an outbreak of hemorrhagic gastroenteritis. A WHO spokesman said the outbreak was not Ebola. DRC is now the fifth African nation to confirm cases of the Ebola outbreak, which began in March. A total of 2,617 infections and 1,427 deaths have been recorded, including in Sierra Leone, Liberia, Guinea and Nigeria. Liberia has seen the most deaths, at more than 600, with the disease confirmed in all regions of the country.” (DW http://bit.ly/1tzIMrw )

Libya on the Brink…The country’s main international airport has been overrun by Islamist militants. “The Islamist groups, led by a militia from the western city of Misrata under the umbrella of “Operation Dawn,” said they had captured the airport in Tripoli on Saturday after more than a month of fighting against the liberal Zintan militias, who have been assigned by the government to guard the airport since 2011…Neighboring Egypt is set to host a regional meeting on Monday to discuss the Libyan crisis. The meeting is expected to include foreign ministers from Egypt, Libya, Tunisia, Algeria, Sudan and Chad, as well as representatives of the Arab League and the African Union’s envoy to Libya.” (LAT http://lat.ms/1tI3rbM)

 Ebola

A Royal Air Force plane carrying a British healthcare worker who contracted Ebola in Sierra Leone – the first Briton to catch the deadly virus – took off from the capital Freetown on Sunday bound for Britain. (Reuters http://bit.ly/XKjE6G)

When disaster strikes a poor country, aid workers from all over the world normally flood the zone. This time, fear of the virus is keeping experts from answering West Africa’s calls for help. (NPR http://n.pr/1qadFkI)

The Philippines is pulling out almost 3,500 workers from three West African states due to the Ebola outbreak, the foreign ministry said on Sunday, a day after Filipino troops in Liberia were ordered to go home. (Reuters http://bit.ly/1qae3zO)

Sierra Leone’s parliament has made the harbouring of Ebola victims a crime punishable by two years’ jail in an attempt to stop the spread of the deadly virus, the justice minister said. (Reuters http://bit.ly/XKjXOX)

A meeting of African health ministers scheduled for early September in Benin has been postponed because of the Ebola epidemic, an official said Sunday. http://yhoo.it/XKlDrz

The worst-ever outbreak of the Ebola virus is taking a heavy toll on west Africa’s economy as crops rot in the fields, mines are abandoned and goods cannot get to market. http://yhoo.it/XKlHrq

Africa

Amnesty International is accusing Mali of holding children  accused of belonging to armed militias in Mali and participating in the country’s ongoing unrest in jails and being held alongside adults. (ABC http://abcn.ws/1tI3HYv)

A member of an East African regional body monitoring a ceasefire in South Sudan died of a heart attack after some monitors were detained by rebels to the north of the country, further complicating a peace process. (Reuters http://bit.ly/1qaehXy)

Niger’s agriculture minister has been arrested on suspicion of involvement in a baby-trafficking network, a spokesman for his political party and legal sources said. (Reuters http://bit.ly/1qaetGq)

MENA

Israeli Prime Minister Benjamin Netanyahu warned Palestinian civilians on Sunday to leave immediately any site where militants are operating, one day after Israel flattened a 13-storey apartment block in Gaza. (Reuters http://reut.rs/1tI3PXM)

The US government says an American held hostage for about two years by an al-Qaida-linked group in Syria has been released. (AP http://bit.ly/1tI4kkR)

In a country where civil liberties remain the prerogative of the powerful and wealthy, the Lebanese gay scene is to be treaded carefully. The recent arrest of 27 members of the LGBT community shows that those not so lucky – those belonging to the more vulnerable tranches of society – are always at risk. (IPS http://bit.ly/1qadXbe)

Italy’s maritime search and rescue service saved 3,500 migrants and found 19 corpses in the Mediterranean since Friday as thousands attempted to cross to Europe by boat over the weekend, the Italian navy said. (Reuters http://bit.ly/1qaeave)

Asia

The authorities in Xinjiang, the ethnically divided region in far western China, said on Saturday that eight people had been executed on charges related to separatist violence, including an attack last year in which a car plowed through tourists near Tiananmen Square in Beijing and erupted in flames. (NYT http://nyti.ms/1tI45Gp)

In Sri Lanka’s poverty-stricken Northern Province, residents say they must stretch the few resources they have in order to survive. (IPS http://bit.ly/1qadSV8)

A new UN report points to a sharp increase in numbers of boat people mostly from Myanmar and Bangladesh.  Activists fear a further surge of refugee boat people, especially ethnic Rohingya fleeing squalid refugee camps and persecution in Myanmar. (VOA http://bit.ly/XKkzUw)

The Americas

Venezuela used to be a world leader in managing malaria, but is now the only country in Latin America where incidence of the disease is increasing. Around 75,000 people were infected last year, and according to government figures, 60% of cases were in Sifontes, a tiny region of the country where gold mining – where workers drill for gold in mosquito-friendly standing water – is booming, and healthcare is scarce. (BBC http://bbc.in/1qaeFFx)

Opinion/Blogs

The Islamic State’s media logic (The Interpreter http://bit.ly/1sltTar)

A New Focus on Peaceful Conflict Resolution at the UNSC? (UN Dispatch http://bit.ly/1slupoD)

Development blog: Does Banning Child Marriage Really Work? (CGD http://bit.ly/1sluzMT)

A Bold New Way of Measuring A Country’s REAL Wealth (UN Dispatch http://bit.ly/1AL9Wie)

Conflict and disaster reporting: Does the public still care? (ODI http://bit.ly/1AL9ZKQ)

If It Looks Corrupt, It Is Corrupt (Global Anticorruption Blog http://bit.ly/XKofpz)

Win $20,000 to be part of the problem? (Chris Blattman http://bit.ly/1ALadBZ)

Which is more important – changing policies, or changing social norms and behaviours (and how are they connected)? (From Poverty to Power http://bit.ly/1ALakx8)

A Storm in a Bucket: Lessons from the Ice Bucket Challenge Controversy (Policy Innovations http://bit.ly/XKoEbla

China Cord Blood Corporation Receives Notice of Transaction Regarding its 7% Senior Convertible Note Due 2017 Held by Golden Meditech

HONG KONG, Aug. 25, 2014 /PRNewswire/ — China Cord Blood Corporation (NYSE: CO) (“CCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company has been informed that Magnum Opus International Holdings Limited (“Magnum”), a private vehicle that is controlled by CCBC Chairman Mr. Yuen KAM and involves the CCBC management team, together with Cordlife Group Limited (“Cordlife”), a Singapore listed company and substantial shareholder of the Company, have agreed to purchase the Company’s outstanding 7% senior convertible note due 2017 (the “Note”) held by Golden Meditech Holdings Limited (“Golden Meditech”), CCBC’s parent company, for a total consideration of approximately $88.1 million.

The Note was originally issued by the Company to Golden Meditech in 2012 with an aggregate principal amount of $50 million. Magnum and Cordlife are each obligated to purchase 50% of the Note, subject to customary closing conditions and satisfaction of all relevant approvals and consents, including but not limited to the approval of Golden Meditech’s independent shareholders.

About China Cord Blood Corporation

China Cord Blood Corporation is the first and largest umbilical cord blood banking operator in China in terms of geographical coverage and the only cord blood banking operator with multiple licenses.  Under current PRC government regulations, only one licensed cord blood banking operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today.  China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services.  For more information, please visit our website at http://www.chinacordbloodcorp.com.        

About Magnum Opus International Holdings Limited

Magnum Opus International Holdings Limited is incorporated in the British Virgin Islands. It is controlled by Mr. Yuen KAM, CCBC’s chairman of the Board, and involves the CCBC management team. Mr. Yuen KAM is also the Chairman and Chief Executive Officer of Golden Meditech.

About Cordlife Group Limited (Bloomberg stock code: CLGL SP)

Incorporated in May 2001, Cordlife Group Limited is a multi-product healthcare company catering to the mother and child segment and a leading cord blood and umbilical cord lining banking services provider. Today, Cordlife operates the largest[1] private cord blood banks in each of Singapore, the Philippines and Indonesia, and is amongst the top three market leaders in Hong Kong and India. Cordlife also holds approximately 10.02% and 31.81% stakes in China Cord Blood Corporation and StemLife Berhad respectively, both of which are their countries’ largest cord blood bank operators. For more information, please visit www.cordlife.com.

[1] Source : Deloitte & Touche Financial Advisory Services Limited report, 10 April 2013

Safe Harbor Statement

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events, performance and results of operations, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in statements filed from time to time with the U.S. Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

For more information, please contact:

China Cord Blood Corporation
Investor Relations Department
Tel: (+852) 3605-8180
Email: ir@chinacordbloodcorp.com

ICR, Inc.
Mr. Bill Zima
Tel: (+86) 10-6583-7511 (China) or (+1) 646-405-5185 (U.S.)
Email: william.zima@icrinc.com